register

News & Trends - Pharmaceuticals

Driving policy changes in heart disease: Uniting clinician and patient advocacy

Health Industry Hub | July 24, 2023 |

Pharma News: Advocacy is the bridge that links patient care with efforts to address social determinants of health, institutionalised prejudices, and structural dislocations faced by patients and communities.

Tanya Hall, CEO of hearts4heart and Dr Warrick Bishop, Cardiologist, Author and Keynote Speaker joined Health Industry Hub to discuss the essential and combined role of clinicians and patients as advocates in cardiovascular health.

They shared the launch of a new resource for heart failure patients at Parliament House. The guide was motivated by identifying unmet clinical needs and aims to provide vital support to those affected by heart failure and their carers.

Dr Bishop delved into the cutting-edge medicines and medical technologies revolutionising heart failure diagnosis and treatment. Moreover, Ms Hall addressed the issue of equity of access to heart failure care in Australia, emphasising the challenges for people living in remote/rural areas, First Nations people, and culturally and linguistically diverse (CALD) populations.

The interview also focused on the collaboration between industry, clinicians, and academia to integrate the patient voice effectively in research and health technology assessment (HTA) activities. hearts4heart’s advocacy efforts and collaboration with the government to drive essential policy changes and secure necessary funding was a key highlight of the conversation.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Roche's immunotherapy drug shows promising results for Australian patients with rare blood cancer

Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer

Health Industry Hub | October 8, 2024 |

Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]

More


News & Trends - Pharmaceuticals

Government seals deal with industry for rare cancer therapy

Government seals deal with industry for rare cancer therapy

Health Industry Hub | October 8, 2024 |

Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]

More


News & Trends - MedTech & Diagnostics

Abbott showcases leadless pacemaker system to local stakeholders

Abbott showcases leadless pacemaker system to local stakeholders

Health Industry Hub | October 8, 2024 |

MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]

More


News & Trends - Pharmaceuticals

Australian scientists pivotal in new drug class from BMS

Australian scientists pivotal in new drug class from BMS

Health Industry Hub | October 8, 2024 |

Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]

More


This content is copyright protected. Please subscribe to gain access.